Skip to main content

Table 1 Patients’ characteristics at ICU admission and at enrollment, according to VAP occurrence within three days after TEE

From: Transesophageal echocardiography-associated tracheal microaspiration and ventilator-associated pneumonia in intubated critically ill patients: a multicenter prospective observational study

Variables

Total (n = 100)

VAP (n = 19)

No VAP (n = 81)

p value

Age (years)

64 (53–72)

63 (58–68)

64 (53–72)

0.94

Female gender

35 (35%)

4 (21.1%)

31 (38.3%)

0.16

Body mass index (Kg/m2)

28 (24–33)

28 (24–32)

27 (24–33)

0.93

SAPS-II at admission

52.6 (± 17.3)

49.7 (± 15.3)

53.2 (± 17.7)

0.41

Comorbidities

    

COPD

8 (8%)

3 (15.8%)

5 (6.2%)

0.17

Diabetes mellitus

33 (33%)

9 (47.4%)

24 (29.6%)

0.14

Swallowing disorder

5 (5%)

2 (10.5%)

3 (3.7%)

0.24

ENT or esophageal surgery

2 (2%)

1 (5.3%)

1 (1.2%)

0.35

Cirrhosis

1 (1%)

0

1 (1.2%)

> 0.99

Immunodeficiency

21 (21%)

4 (21.1%)

17 (21.0%)

> 0.99

Steroid therapy

17 (17%)

3 (15.8%)

14 (17.3%)

> 0.99

Complications before TEE

    

Acute respiratory distress syndrome

38 (38%)

8 (42.1%)

30 (37.0%)

0.68

Shock

74 (74%)

13 (68.4%)

61 (75.3%)

0.54

VAP

21 (21%)

6 (31.6%)

15 (18.5%)

0.21

Endotracheal intubation characteristics

    

Reason for mechanical ventilation

   

0.83

Acute respiratory distress

47 (47%)

10 (52.6%)

37 (45.7%)

 

Shock

17 (17%)

3 (15.8%)

14 (17.3%)

 

Coma

25 (25%)

5 (26.3%)

20 (24.7%)

 

Others

11 (11%)

1 (5.3%)

10 (12.4%)

 

ETT type

   

0.13

Standard

58 (58.6%)

7 (38.9%)

51 (63.0%)

 

Subglottic secretion drainage tube

40 (40.4%)

11 (61.1%)

29 (35.8%)

 

Others

1 (1.0%)

0

1 (1.2%)

 

Tracheal tube size (mm)

7.5 (7.5–8)

8.0 (7.5–8)

7.5 (7.5–8)

0.02

Distance from ETT tip to the carina (cm)

3.7 (2.5–5.0)

3.1 (2.4–4.9)

3.7 (2.7–5.3)

0.50

At enrollment

    

SOFA

10 (5–13)

10 (5–13)

10 (5–13)

0.96

Duration of prior mechanical ventilation (d)

3 (1–8)

5 (1–9)

2 (1–8)

0.35

RASS

− 4 (− 5 to − 2)

− 5 (− 5 to − 2)

− 4 (− 5 to − 2)

0.59

Oral decontamination-to-TEE time (h)

3 (2–6)

4 (1–6)

3 (2–6)

0.95

Ventilation parameters

    

Mode of ventilation

   

0.88

Assist-control ventilation

74 (74%)

14 (73.7%)

60 (74.1%)

 

Pressure support ventilation

25 (25%)

5 (26.3%)

20 (24.7%)

 

Others

1 (1%)

0

1 (1.2%)

 

Tidal volume (mL)

400 (370–450)

415 (365–450)

400 (367–445)

0.68

Respiratory rate (/min)

25 (22–32)

26 (22–33)

25 (21–31)

0.36

Positive end-expiratory pressure (cmH2O)

6 (5–10)

5 (5–8)

6 (5–10)

0.19

Peak pressure (cmH2O)

32 (± 10)

32 (± 9)

32 (± 10)

0.91

Plateau pressure (cmH2O)

21 (± 6)

21 (± 6)

21 (± 6)

0.92

  1. Values are expressed as mean (± SD) or median (IQR) as appropriate. VAP ventilator-associated pneumonia, TEE transesophageal echocardiography, SAPS II Simplified Acute Physiology Score II, COPD chronic obstructive pulmonary disease, ENT ear nose throat, ETT endotracheal tube, SOFA score Sequential Organ Failure Assessment, RASS Richmond Agitation and Sedation Scale